Joshua Dennerlein
Stock Analyst at B of A Securities
(2.30)
# 2,378
Out of 4,829 analysts
91
Total ratings
47.54%
Success rate
-4.66%
Average return
Main Sectors:
Stocks Rated by Joshua Dennerlein
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
SUI Sun Communities | Maintains: Underperform | $124 → $132 | $124.85 | +5.73% | 3 | May 12, 2025 | |
MSCI MSCI Inc. | Initiates: Neutral | $585 | $564.19 | +3.69% | 1 | Apr 10, 2025 | |
WELL Welltower | Maintains: Buy | $221 → $242 | $143.79 | +68.30% | 7 | Feb 18, 2025 | |
FVR FrontView REIT | Initiates: Buy | $22 | $12.34 | +78.29% | 1 | Oct 28, 2024 | |
GTY Getty Realty | Upgrades: Buy | $31 → $34 | $28.38 | +19.80% | 3 | Oct 21, 2024 | |
AHR American Healthcare REIT | Maintains: Buy | $27 → $31 | $34.14 | -9.20% | 2 | Sep 24, 2024 | |
NHI National Health Investors | Initiates: Buy | $92 | $76.16 | +20.80% | 1 | Sep 24, 2024 | |
ESS Essex Property Trust | Downgrades: Neutral | $307 → $321 | $286.47 | +12.05% | 3 | Sep 24, 2024 | |
LINE Lineage | Initiates: Buy | $100 | $48.12 | +107.81% | 1 | Aug 19, 2024 | |
CPT Camden Property Trust | Upgrades: Buy | $111 → $147 | $118.50 | +24.05% | 4 | Aug 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $144 → $189 | $162.82 | +16.08% | 3 | Aug 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $45 → $40 | $52.72 | -24.13% | 4 | May 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $18 → $25 | $17.37 | +43.93% | 2 | Apr 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $33 → $31 | $35.29 | -12.16% | 11 | Jan 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $48 → $53 | $64.52 | -17.85% | 9 | Jan 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $18 → $6 | $6.39 | -6.10% | 1 | Nov 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $42 → $33 | $42.44 | -22.24% | 1 | Oct 31, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $20 → $15 | $15.70 | -4.46% | 2 | Oct 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $52 | $55.68 | -6.61% | 1 | Oct 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $17.82 | - | 4 | Oct 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $67 → $54 | $60.90 | -11.33% | 4 | Sep 26, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $9 → $8 | $5.16 | +55.04% | 9 | Aug 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $27 | $11.78 | +129.20% | 1 | Jun 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $34 | $18.17 | +84.37% | 5 | Nov 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $31.84 | - | 4 | Aug 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $76 → $78 | $72.49 | +7.60% | 2 | Jun 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $52 → $47 | $41.19 | +14.11% | 2 | Jan 20, 2022 |
Sun Communities
May 12, 2025
Maintains: Underperform
Price Target: $124 → $132
Current: $124.85
Upside: +5.73%
MSCI Inc.
Apr 10, 2025
Initiates: Neutral
Price Target: $585
Current: $564.19
Upside: +3.69%
Welltower
Feb 18, 2025
Maintains: Buy
Price Target: $221 → $242
Current: $143.79
Upside: +68.30%
FrontView REIT
Oct 28, 2024
Initiates: Buy
Price Target: $22
Current: $12.34
Upside: +78.29%
Getty Realty
Oct 21, 2024
Upgrades: Buy
Price Target: $31 → $34
Current: $28.38
Upside: +19.80%
American Healthcare REIT
Sep 24, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $34.14
Upside: -9.20%
National Health Investors
Sep 24, 2024
Initiates: Buy
Price Target: $92
Current: $76.16
Upside: +20.80%
Essex Property Trust
Sep 24, 2024
Downgrades: Neutral
Price Target: $307 → $321
Current: $286.47
Upside: +12.05%
Lineage
Aug 19, 2024
Initiates: Buy
Price Target: $100
Current: $48.12
Upside: +107.81%
Camden Property Trust
Aug 12, 2024
Upgrades: Buy
Price Target: $111 → $147
Current: $118.50
Upside: +24.05%
Aug 12, 2024
Upgrades: Buy
Price Target: $144 → $189
Current: $162.82
Upside: +16.08%
May 20, 2024
Downgrades: Underperform
Price Target: $45 → $40
Current: $52.72
Upside: -24.13%
Apr 1, 2024
Upgrades: Buy
Price Target: $18 → $25
Current: $17.37
Upside: +43.93%
Jan 16, 2024
Downgrades: Neutral
Price Target: $33 → $31
Current: $35.29
Upside: -12.16%
Jan 16, 2024
Upgrades: Buy
Price Target: $48 → $53
Current: $64.52
Upside: -17.85%
Nov 7, 2023
Downgrades: Underperform
Price Target: $18 → $6
Current: $6.39
Upside: -6.10%
Oct 31, 2023
Downgrades: Neutral
Price Target: $42 → $33
Current: $42.44
Upside: -22.24%
Oct 10, 2023
Downgrades: Underperform
Price Target: $20 → $15
Current: $15.70
Upside: -4.46%
Oct 10, 2023
Downgrades: Neutral
Price Target: $52
Current: $55.68
Upside: -6.61%
Oct 10, 2023
Upgrades: Buy
Price Target: n/a
Current: $17.82
Upside: -
Sep 26, 2023
Maintains: Underperform
Price Target: $67 → $54
Current: $60.90
Upside: -11.33%
Aug 11, 2023
Downgrades: Underperform
Price Target: $9 → $8
Current: $5.16
Upside: +55.04%
Jun 13, 2023
Initiates: Underperform
Price Target: $27
Current: $11.78
Upside: +129.20%
Nov 14, 2022
Upgrades: Buy
Price Target: $28 → $34
Current: $18.17
Upside: +84.37%
Aug 24, 2022
Upgrades: Buy
Price Target: n/a
Current: $31.84
Upside: -
Jun 2, 2022
Upgrades: Buy
Price Target: $76 → $78
Current: $72.49
Upside: +7.60%
Jan 20, 2022
Downgrades: Underperform
Price Target: $52 → $47
Current: $41.19
Upside: +14.11%